Afimoxifene Completed Phase 2 Trials for Estrogen Receptor Positive Breast Cancer / Ductal Breast Carcinoma In Situ / Estrogen Receptor-Positive Breast Cancer Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| https://clinicaltrials.gov/ct2/show/ | 4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ |